Chief Medical Officer

Kate Madigan has served as the Company’s Chief Medical Officer since March 2022.

Previous Experience
Kate served as Vice President, Head of Clinical Development at Syros Pharmaceuticals. Prior to joining Syros, she served as Senior Medical Director at Alnylam Pharmaceuticals, and was a Medical Director in Biogen’s Rare Disease Innovation Unit. Kate previously held various academic positions of increasing responsibility at University of California San Diego/ Rady Children’s Hospital San Diego.

Kate received a B.A. in Asian Studies from Dartmouth College and an M.D. from the Keck School of Medicine of the University of Southern California.